Supra Medical Corp. v. McGonigle

955 F. Supp. 374, 1997 U.S. Dist. LEXIS 986, 1997 WL 45039
CourtDistrict Court, E.D. Pennsylvania
DecidedJanuary 31, 1997
DocketCivil Action 96-3737
StatusPublished
Cited by19 cases

This text of 955 F. Supp. 374 (Supra Medical Corp. v. McGonigle) is published on Counsel Stack Legal Research, covering District Court, E.D. Pennsylvania primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Supra Medical Corp. v. McGonigle, 955 F. Supp. 374, 1997 U.S. Dist. LEXIS 986, 1997 WL 45039 (E.D. Pa. 1997).

Opinion

MEMORANDUM

RAYMOND J. BRODERICK, District Judge.

Plaintiff Supra Medical Corp. instituted this action on May 16, 1996 against eight defendants pursuant to the Racketeer Influ *376 enced and Corrupt Organizations Act (“RICO”), 18 U.S.C. §§ 1961 et seq., alleging that the defendants had engaged in a scheme to defraud the Plaintiff by misappropriating the Plaintiffs proprietary interest in its medical scanner equipment and technology.

Presently before the Court are the motions of three defendants who are residents of the United Kingdom to dismiss Plaintiffs complaint pursuant to Fed.R.Civ.P. 12(b)(1), 12(b)(2), 12(b)(5), and 12(b)(6), as well as on the grounds of forum non conveniens. The moving defendants are the United Medical and Dental Schools of Guy’s and St. Thomas’s Hospitals (hereinafter “UMDS” or “the Schools”), Dr. Mary Dyson, and Hugh Lewis (hereinafter collectively the “UMDS Defendants”).

The UMDS Defendants move to dismiss under Rule 12(b)(1) on the grounds that the Schools, and also the individuals acting in the scope of their employment with the Schools, are immune from suit as agencies or instru-mentalities of the United Kingdom pursuant to the Foreign Sovereign Immunities Act, 28 U.S.C. §§ 1602 et seq.; under Rule 12(b)(2) on the grounds that the Court may not exercise personal jurisdiction over them; under Rule 12(b)(5) on the grounds that Plaintiff violated the Hague Convention in effectuating service of process; under Rule 12(b)(6) for the reasons set forth in the motion of defendants James R. McGonigle and Long-port, Inc., filed on June 19,1996; and finally, on the grounds of forum non conveniens.

After permitting the parties roughly three months to conduct limited discovery into the jurisdictional issues raised by the UMDS Defendants’ motions, and upon considering the parties’ legal memoranda, affidavits, and oral argument to the Court on January 17, 1997, the Court will deny the UMDS Defendants’ 12(b)(1), 12(b)(2), 12(b)(5), and forum non conveniens motions for the reasons set forth in this Memorandum. By Order dated today, the Court will also deny the UMDS Defendants’ Rule 12(b)(6) motion.

I. Background

Based on the exhibits and affidavits submitted to the Court in connection with the UMDS Defendants’ motions to dismiss, the Court summarizes the factual contentions of the parties as follows: The Plaintiff Supra Medical Corp. was incorporated in Delaware in 1985 under the name Ventnor Corporation and is located in Chadds Ford, Pennsylvania. The Plaintiff was listed on the American Stock Exchange in 1992 as Topox, Inc., and later that year changed its name to the current Supra Medical Corp.

In 1990, the Plaintiff acquired patents and patent applications to certain medical scanner technology for use in treating wounds, skin ulcerations, and pressure sores. In 1991, the Plaintiff acquired the patents, licenses and technology to the Supra Scanner, a medical device proposed for use in diagnosing skin cancers, burns, and other types of wounds. One key element of the Supra Scanner, however, was acquired under an exclusive sublicense agreement with the National Aeronautics and Space Administration. Plaintiffs Exh. 39 (Supra Medical Corp.1993 Annual Report).

The Supra Scanner combines ultrasound, voice-activation, and computer technology in a single instrument to produce high resolution monochromatic or color images of skin tissue up to approximately 1.5 inches beneath the skin. Such technology permits physicians to assess skin wounds without resorting to exploratory surgery.

Plaintiff alleges the following scheme by the Defendants to misappropriate its technology: Defendants James McGonigle and Philip Loori were officers and directors of the Plaintiff at the time it acquired patents and patent applications for the Supra Scanner technology in 1991. Soon thereafter, the Plaintiff; Defendant United Medical and Dental Schools of Guy’s and St. Thomas’s Hospitals; and Defendant Dr. Mary Dyson, the chair of the Schools’ Division of Anatomy and Tissue Repair Unit, agreed to establish a program in England to test the efficacy of the Supra Scanner and ultimately establish “wound healing centers” utilizing the Supra Scanner.

To accomplish this goal the Plaintiff provided $50,000 and several Supra Scanner devices to the Schools, entered into an “Agreement in Principle” in late 1992, and *377 established a U.K. company called Supra Medical International, Ltd. The Plaintiff also accepted Defendant Dyson as a member of its Board of Directors. Over the next year, Dr. Dyson and the Schools tested the Supra Scanner, engaging the services of Defendant Hugh Lewis as an independent contractor. Defendant Lewis entered into a confidentiality agreement with Supra Medical on June 8, 1993, executed by him and Defendant Dyson as chairman and executive officer of Supra Medical International, Ltd. Defendant Lewis later refused to sign a similar agreement acknowledging that all work he performed would be the property of the Plaintiff.

At about the same time that the Plaintiff was establishing a relationship with the UMDS Defendants in 1992, Defendants MeGonigle and Loori resigned as officers and directors of Plaintiff and sold most of then-shares in Plaintiffs common stock. According to the Plaintiff, Defendants MeGonigle and Loori soon thereafter established then-own corporation, Defendant Longport, Inc., to pursue the same line of business.

In 1994, Defendants MeGonigle and Loori proposed a joint venture between Longport and the Plaintiff regarding the Supra Scanner technology. The Plaintiff apparently declined this offer. Immediately thereafter, Defendant Dyson resigned from Plaintiffs board of directors and made a presentation of the Supra Scanner to one of Plaintiffs competitors over Plaintiffs objections. Plaintiff alleges that Dyson also engaged in business discussions with Longport.

In 1995, Defendants MeGonigle, Loori, and Longport announced a joint venture with the UMDS Defendants to establish wound healing clinics using medical devices which the Plaintiff claims incorporate its Supra Scanner proprietary technology. Longport and the UMDS defendants are currently developing and testing a medical scanner device at wound healing centers in England and the United States. See Plaintiffs Exhs. 53-59.

The Plaintiff filed this action on May 16, 1996, alleging that from in or about 1992, the UMDS Defendants and Defendants MeGoni-gle, Loori, and Longport devised and joined in a scheme to misappropriate the Plaintiffs Supra Scanner technology. The complaint alleges mail and wire fraud violations as well as interstate transportation of stolen property. The Plaintiff seeks damages in excess of $7 million and a permanent injunction against the Defendants from utilizing or profiting from the Plaintiffs technology.

II. Defendants’ Rule 12(b)(1) Motion to Dismiss Under the Foreign Sovereign Immunities Act, 28 U.S.C. §§ 1602-11

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Crystallex International Corp. v. Venezuela
251 F. Supp. 3d 758 (D. Delaware, 2017)
LaLoup v. United States
29 F. Supp. 3d 530 (E.D. Pennsylvania, 2014)
Tow v. Rafizadeh (In Re Cyrus II Partnership)
392 B.R. 248 (S.D. Texas, 2008)
Bd Regents Univ TX v. Nippon Tele Telegr
478 F.3d 274 (Fifth Circuit, 2007)
USX Corp. v. Adriatic Insurance
345 F.3d 190 (Third Circuit, 2003)
Usx Corporation v. Adriatic Insurance Company
345 F.3d 190 (First Circuit, 2003)
Kelly v. Syria Shell Petroleum Development B.V.
213 F.3d 841 (Fifth Circuit, 2000)
Northeastern Power Co. v. Balcke-Durr, Inc.
49 F. Supp. 2d 783 (E.D. Pennsylvania, 1999)
Resnick v. Manfredy
52 F. Supp. 2d 462 (E.D. Pennsylvania, 1999)
Remick v. Manfredy
52 F. Supp. 2d 452 (E.D. Pennsylvania, 1999)
U.S. Titan, Inc. v. Guangzhou Zhen Hua Shipping Co.
16 F. Supp. 2d 326 (S.D. New York, 1998)
Santana Products, Inc. v. Bobrick Washroom Equipment
14 F. Supp. 2d 710 (M.D. Pennsylvania, 1998)
Harry Miller Co. v. Carr Chem Inc.
5 F. Supp. 2d 295 (E.D. Pennsylvania, 1998)

Cite This Page — Counsel Stack

Bluebook (online)
955 F. Supp. 374, 1997 U.S. Dist. LEXIS 986, 1997 WL 45039, Counsel Stack Legal Research, https://law.counselstack.com/opinion/supra-medical-corp-v-mcgonigle-paed-1997.